ANGIOCRINE BIOSCIENCE

angiocrine-bioscience-logo

Angiocrine Bioscience has developed a cellular platform for amplifying stem and progenitor cells, in both human and mouse models, by recapitulating the proliferative stimulation of the in vivo vascular niche in vitro. The expansion capacity is on an unprecedented scale when compared to any other competing technology, and it is achieved without the requirement for costly media additives. This process can meet the needs of a broad range of therapeutic, diagnostic, and research applications. We look forward to the expansive application of this technology to help fulfill the promise of tissue-specific engineering and organ-regeneration.

#SimilarOrganizations #People #Website #More

ANGIOCRINE BIOSCIENCE

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Therapeutics

Founded:
2012-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.angiocrinebioscience.com

Total Employee:
1+

Status:
Active

Contact:
530-745-9560

Email Addresses:
[email protected]

Total Funding:
62.12 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins Nginx


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

john-jaskowiak_image

John Jaskowiak
John Jaskowiak Chief Operating Officer @ Angiocrine Bioscience
Chief Operating Officer
2017-11-01

jeffrey-port_image

Jeffrey Port
Jeffrey Port Co-Founder & Chairman @ Angiocrine Bioscience
Co-Founder & Chairman
2012-11-01

paul-finnegan_image

Paul Finnegan
Paul Finnegan Chief Executive Officer @ Angiocrine Bioscience
Chief Executive Officer
2015-05-01

c-geoffrey-davis_image

C. Geoffrey Davis
C. Geoffrey Davis President and CSO @ Angiocrine Bioscience
President and CSO
2015-06-01

john-fraser_image

John Fraser
John Fraser Chief Scientific Officer @ Angiocrine Bioscience
Chief Scientific Officer
2019-08-01

shahin-rafii_image

Shahin Rafii
Shahin Rafii Scientific Founder @ Angiocrine Bioscience
Scientific Founder

john-lomoro_image

John Lomoro
John Lomoro Chief Financial Officer @ Angiocrine Bioscience
Chief Financial Officer
2021-04-01

not_available_image

John Klacking
John Klacking Co-Founder @ Angiocrine Bioscience
Co-Founder
2011-02-01

Founder


jeffrey-port_image

Jeffrey Port

not_available_image

John Klacking

shahin-rafii_image

Shahin Rafii

Official Site Inspections

http://www.angiocrinebioscience.com

  • Host name: 201.34.196.104.bc.googleusercontent.com
  • IP address: 104.196.34.201
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Angiocrine Bioscience"

Our Story - Angiocrine Bioscience

Angiocrine Bioscience is a private, clinical stage cell and gene therapy company based in San Diego, California. Angiocrine Bioscience began as a start-up located within Weill Cornell Medical College (New York City) and then โ€ฆSee details»

Angiocrine Bioscience - PitchBook

Www.angiocrinebioscience.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 11696 Sorrento Valley Road; Suite 200; San Diego, CA 92121; United StatesSee details»

Angiocrine Bioscience, Inc. | LinkedIn

Angiocrine Bioscience is a private, clinical stage engineered cell therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function โ€ฆSee details»

Angiocrine Bioscience, Inc. Company Profile | San Diego, CA ...

Find company research, competitor information, contact details & financial data for Angiocrine Bioscience, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

Angiocrine Bioscience - Crunchbase Company Profile โ€ฆ

Angiocrine Bioscience has developed a cellular platform for amplifying stem and progenitor cells, in both human and mouse models, by recapitulating the proliferative stimulation of the in vivo vascular niche in vitro.See details»

Angiocrine Bioscience, Inc. Overview | SignalHire Company Profile

Organization Website: angiocrinebioscience.com : Phone Number (877) 784-8496: Angiocrine Bioscienc... industries Biotech: Headquarters Location: 11575 Sorrento Valley Rd, San Diego, โ€ฆSee details»

Executive Leadership - Angiocrine Bioscience

Dr. Finnegan is Chief Executive Officer of Angiocrine Bioscience. He has more than 20 years of life science management experience in the biotechnology, pharmaceutical, and healthcare industries โ€“ including extensive operational โ€ฆSee details»

Angiocrine Bioscience - Overview, News & Similar companies

May 2, 2020 Angiocrine Bioscience contact info: Phone number: (858) 345-1396 Website: www.angiocrinebioscience.com What does Angiocrine Bioscience do? Angiocrine Bioscience โ€ฆSee details»

Angiocrine Bioscience - Org Chart, Teams, Culture & Jobs | The Org

Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function โ€ฆSee details»

Angiocrine Bioscience, Inc. Information - RocketReach

Angiocrinebioscience.com; gmail.com; View Similar People. Related Companies ViaCyte. 36 $22.6m Evofem Biosciences. 66 $11.4m Mirati Therapeutics. 287 $72.8m Evoke Canale. 139 โ€ฆSee details»

Angiocrine Bioscience, Inc. - Drug pipelines, Patents ... - Patsnap

Dec 18, 2024 angiocrinebioscience.com. Holding Company | 2012 | New York, United States | 10-50 | angiocrinebioscience.com. Last update 18 Dec 2024. Overview. Pipeline. Deal. โ€ฆSee details»

Angiocrine Bioscience | VentureRadar

Dec 1, 2024 Angiocrine Bioscience develops research and therapeutic products based on stem cell- and endothelial cell-related technologies. ... Find out more about Angiocrine Bioscience, โ€ฆSee details»

Board of Directors - Angiocrine Bioscience

Dr. Finnegan is Chief Executive Officer of Angiocrine Bioscience. He has more than 20 years of life science management experience in the biotechnology, pharmaceutical, and healthcare โ€ฆSee details»

Angiocrine Bioscience - Company Profile - Tracxn

Oct 21, 2024 Angiocrine Bioscience - Therapeutics based on genetically modified endothelial cells.. Raised a total funding of $4M over 1 round from 2 investors. Angiocrine Bioscience has โ€ฆSee details»

Angiocrine Bioscience - Craft

Angiocrine Bioscience has 5 employees at their 1 location and $4 m in total funding,. See insights on Angiocrine Bioscience including office locations, competitors, revenue, financials, โ€ฆSee details»

Angiocrine Bioscience - Work in biotech

Angiocrine Bioscience is developing curative cell therapies to use for regenerative medicine. Endothelial cells that line blood vessels are important for organ function, but also play an โ€ฆSee details»

https://www.angiocrinebioscience.com

Https://www.angiocrinebioscience.comSee details»

Science - Angiocrine Bioscience

What are vascular niches? Endothelial cells and adult progenitor (stem) cells congregate to form vascular โ€˜stem cellโ€™ niches. These niches have been found in nearly all tissues and organs.See details»

Working at Angiocrine Bioscience - Zippia

Mar 14, 2024 Find out what it's like to work at Angiocrine Bioscience. See what kind of people work at Angiocrine Bioscience, career paths working at Angiocrine Bioscience, company โ€ฆSee details»

linkstock.net © 2022. All rights reserved